1. Home
  2. GUNN vs QURE Comparison

GUNN vs QURE Comparison

Compare GUNN & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gunnison Copper Corp. American Depositary Shares (each representing thirty (30) Common Shares)

GUNN

Gunnison Copper Corp. American Depositary Shares (each representing thirty (30) Common Shares)

N/A

Current Price

$5.27

Market Cap

2.7B

Sector

N/A

ML Signal

N/A

Logo uniQure N.V.

QURE

uniQure N.V.

N/A

Current Price

$19.35

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GUNN
QURE
Founded
N/A
1998
Country
United States
Netherlands
Employees
106
248
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.1B
IPO Year
2011
2013

Fundamental Metrics

Financial Performance
Metric
GUNN
QURE
Price
$5.27
$19.35
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
★ $58.14
AVG Volume (30 Days)
69.5K
★ 1.7M
Earning Date
03-24-2027
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 29.67
EPS
★ N/A
N/A
Revenue
N/A
★ $13,107,000.00
Revenue This Year
$593.30
$39.49
Revenue Next Year
$10.53
$402.79
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.56
$8.73
52 Week High
$9.16
$51.72

Technical Indicators

Market Signals
Indicator
GUNN
QURE
Relative Strength Index (RSI) 21.80 31.36
Support Level N/A $13.96
Resistance Level $8.91 $26.07
Average True Range (ATR) 0.71 1.70
MACD -0.29 -0.05
Stochastic Oscillator 3.09 0.49

Price Performance

Historical Comparison
GUNN
QURE

About GUNN Gunnison Copper Corp. American Depositary Shares (each representing thirty (30) Common Shares)

Gunnison Copper Corp is engaged in the acquisition, exploration, and development of copper mineral properties and the construction and operation of copper mines in Arizona, USA. The company is focused on the development of the Gunnison Copper Project, which is designed to be a large-scale open pit operation producing finished copper cathodes. The company operates in two reportable operating segments in the United States: Gunnison and Johnson Camp Mine.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: